According to CDC estimates, 139 million American adults (42%) are obese and 34 million Americans have diabetes. Every year, Americans spend upwards of $60 billion on gym memberships, diet plans, and other services dedicated to weight loss. But for many, sticking to a diet is a problem, and for some, knowing where to start can be challenging. Could a personalized diet plan based on genetic testing and real-time monitoring be a helpful tool?
The Challenges of COVID-19 Human Challenge Trials
by Stephanie Holden, PhD | November 23rd, 2020
Would you be willing to voluntarily get infected with a virus for the chance to help advance a vaccine? COVID-19 has killed over a million people worldwide, spurring vaccine development at an unprecedented pace, but for many it still doesn’t feel fast enough. If you’re relatively young and healthy, this may be all the more […]
by Alexandra Ramsey | November 24th, 2020
Engaging in constant retail therapy or following the latest fashion trends might soon lead to a bacterial cellulose sweater in your dresser or a pair of mushroom-based Adidas sneakers in your closet. Big-name clothing brands around the world are starting to partner with biotechnology companies, paving the way for a bio-revolution in the textiles industry. […]
Custom nutrition: Are your genes the only diet plan you need?
by Hayley McCausland, BS | August 20, 2020
How telehealth is transforming healthcare in the COVID-19 era
by Nnamdi Nelson, PhD | August 18, 2020
Telehealth has become a broad term used to describe the use of distance telecommunications to deliver medical care, encompassing preventative care, diagnosis, disease management, and patient education.
Intrapatient Multi-omics: Defining the New Standards in Medicine
by Wadie D. Mahauad-Fernandez, PhD | August 6, 2020
The current model of medicine, which is based on the treatment of diseases via a “one-size-fits-all” approach, is outdated, inefficient, costly, and in some cases harmful. New technological and scientific discoveries have demonstrated that diseases are extremely heterogeneous and vary from one patient to another.
Sickle cell disease: A case study of systemic racial disparities in US healthcare
by Amy Guo, BS | August 6, 2020
Institutional policies and implicit biases have resulted in neglect at the point of care, higher rates of insurance loss, and a divestment of resources from diseases primarily impacting Black people. These inequities are evident in the past and present state of care in the US for sickle cell disease (SCD), an inherited blood disorder prevalent in those with sub-Saharan African or other malaria-endemic regional ancestry.
Drug pricing in the US: A Perspective
by Neha P. Paranjape, PhD | June 15, 2020
Despite advances in the drug development process, the price of drugs in the United States continues to rise.
Recent outbreaks: a focus on COVID-19 and Ebola
by Martina de Majo, PhD | June 9, 2020
Until the 1900s, infectious diseases were responsible for the highest number of deaths worldwide.
Resistant to Antibiotic Resistance: Why is Bankruptcy a Reality for Many Small to Mid-sized Commercial-stage Antibiotic Companies?
by Cara He, BA | June 8, 2020
“We have four bankruptcies and three companies on the ropes, and not many will invest in this space”